|Bid||0.00 x 1100|
|Ask||0.00 x 1100|
|Day's Range||119.78 - 122.99|
|52 Week Range||113.57 - 150.40|
|PE Ratio (TTM)||20.22|
|Earnings Date||Aug 1, 2018 - Aug 6, 2018|
|Forward Dividend & Yield||3.84 (3.31%)|
|1y Target Est||128.86|
Clorox Co. said it set a new $2 billion stock repurchase program, to replace the existing $750 million program. Based on Wednesday's stock closing price of $119.44, and with 129.5 million shares outstanding as of April 18, the new program represents up to 13% of the consumer products company's shares outstanding. "The company is initiating this stock repurchase program, which demonstrates our commitment to driving value for our stockholders while maintaining a strong balance sheet," said Chief Executive Benno Dorer.
OAKLAND, Calif., May 24, 2018 /PRNewswire/ -- The Clorox Company (CLX) today announced its board of directors has authorized the company to repurchase its stock in the open market for an aggregate purchase price of up to $2 billion. This stock repurchase program is designed to return value to Clorox stockholders and is in addition to the company's evergreen repurchase program to reduce or eliminate dilution in connection with issuances of stock under the company's stock incentive plans. "The company is initiating this stock repurchase program, which demonstrates our commitment to driving value for our stockholders while maintaining a strong balance sheet," said Chairman and CEO Benno Dorer.
OAKLAND, Calif. , May 21, 2018 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today announced that its board of directors has declared a quarterly dividend of 96 cents per share on the company's common ...
In this daily bar chart of CLX, below, we can see that prices have been in a downtrend all year. The daily On-Balance-Volume (OBV) line peaked in late December and its four month decline tells us that sellers of CLX have been more aggressive. The Moving Average Convergence Divergence (MACD) oscillator crossed to the upside in early May for a cover shorts buy signal (a buy in a downtrend) but recently the oscillator has begun to narrow and turn to the downside again.
Kimberly-Clark (KMB) is showing improvement on both the sales and earnings fronts. However, near-term headwinds continue to restrict the company’s upside. Kimberly-Clark’s top line is benefiting from an improvement in its volumes and favorable currency rates. However, increased promotional spending to drive volumes is leading to lower net price realizations and, in turn, lower organic sales.
Clorox (CLX) has managed to report improved sales and earnings despite facing tough YoY (year-over-year) comparisons. Clorox’s efficient marketing and strong portfolio of industry-leading brands and innovation-led products have supported its top line growth. Clorox’s margins are expected to remain constant in the coming quarters, as inflation in commodities and logistics costs are expected to hurt its profitability.
Shares of household and personal care product manufacturers Procter & Gamble (PG), Clorox (CLX), Colgate-Palmolive (CL), and Kimberly-Clark (KMB) are underperforming the broader markets. Despite the fact that these companies have reported improvements in their volumes and earnings growth rates, investors don’t seem interested in giving them the benefit of the doubt.
The dividend yields of CPG (consumer packaged goods) manufacturers are inching up. For instance, Procter & Gamble (PG) and Kimberly-Clark (KMB) have current dividend yields of close to 4% based on their closing prices on May 15.
On CNBC's "Mad Money Lightning Round" , Jim Cramer said he would not buy Chesapeake Energy Corporation (NYSE: CHK ) because there's too much natural gas. Cramer would take profits in Adaptimmune ...
OAKLAND, Calif. , May 15, 2018 /PRNewswire/ -- The Clorox Company (NYSE: CLX) announced today that Chairman and Chief Executive Officer Benno Dorer and Chief Financial Officer Kevin Jacobsen will be featured ...
If you’re looking for the best income-producing investment, stocks that consistently increase their annual dividend are a great way to build passive income. While there is no best way to invest for income, there are some different methods you can use to grow your investment portfolio without taking a lot of risks. Here’s three stocks yielding 1%, 3%, and 5%, that I believe will help you generate passive income over the long haul.
NEW YORK, May 14, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Viasat ...
Clorox (CLX) is gaining from a robust surprise trend as well progress on its 2020 Strategy and e-commerce initiatives. However, the company's soft margins are keeping us on the sidelines.
Moody's Investors Service, ("Moody's") today assigned a Baa1 rating to $500 million of senior unsecured notes being offered by The Clorox Company. Net proceeds will be used to refinance upcoming ...
Ahead of today's trading session, WallStEquities.com evaluates Newell Brands Inc. (NYSE: NWL), The Clorox Co. (NYSE: CLX), GoPro Inc. (NASDAQ: GPRO), and Hostess Brands Inc. (NASDAQ: TWNK). Hoboken, New Jersey headquartered Newell Brands Inc.'s stock finished Wednesday's session 1.28% lower at $26.96 with a total trading volume of 4.65 million shares.
International Flavors and Fragrances (IFF) announced its 1Q18 earnings during market hours on May 7. In this series, we’ll discuss IFF’s 1Q18 earnings, revenues, the performances of its reporting segments, and its Frutarom Industries acquisition.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Consumer Goods sector is rising.
OAKLAND, Calif., May 8, 2018 /PRNewswire/ -- Just in time for health-minded individuals who are seeking a spring reboot, Renew Life Ultimate Flora Probiotics, a leading manufacturer of digestive health solutions, introduces its first product line of clinically formulated, non-GMO probiotics + organic prebiotics to support digestive and immune health plus other specific needs. A healthy gut is the key to good digestion, immune health, energy, mood, and more. One way to help restore and maintain that balance is to regularly consume both probiotics and prebiotics, which work together synergistically to promote gut health.
Two analysts lowered their target prices for Clorox stock after it posted its fiscal 3Q18 results. Morgan Stanley reduced its price target to $113 from $116. Among the 16 analysts providing recommendations for Clorox stock, 13 of them have recommended a “hold,” two have recommended a “buy,” and one has recommended a “sell.” Analysts are maintaining a price target of $130.79 on CLX stock, which represents an upside potential of 12.8% based on its closing price of $116 on May 2.
Clorox (CLX) continues to disappoint investors with its sluggish margin performance. The trend is likely to continue in the near term. Branded consumer packaged goods manufacturers in the United States are grappling with increased costs related to raw materials and packaging. Higher transportation costs, exacerbated by carrier supply restraints and driver shortages, are further pressuring profitability.
Based on the latest short interest report on April 13, International Flavors and Fragrances’ short interest has risen to its highest level since the beginning of 2018. IFF’s short interest as a percentage of its outstanding shares stands at 1.8% as of April 13 as compared to 1.3% at the beginning of the year. However, IFF stock fell 9.8% during this period, indicating the prevailing weakness in the stock.
Clorox’s (CLX) Cleaning segment, which includes laundry, home care, and professional products, saw a 3% growth in sales led by a 4% improvement in volumes. The home care category continued to shine and registered high-single-digit growth in volumes and sales. The category marked record shipments of namesake brands such as Clorox Disinfecting Wipes. Innovation-based new product launches, strong merchandising, and a severe cold and flu season contributed to sales of disinfecting wipes.
Clorox (CLX) reported net sales of $1.5 billion in fiscal 3Q18, which was slightly higher than analysts’ expectation. It increased 2.7% on a YoY (year-over-year) basis. It improved sales in fiscal 3Q18 despite a tough YoY comparison and a challenging retail environment. In fiscal 3Q17, its volumes improved 7%, while its sales gained 4%.